Antonio Mollo Selected Research

Endometrial Hyperplasia

9/2022	Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and early endometrial cancer to conservative treatment.
1/2021	Clinical Predictive Factors of Response to Treatment in Patients Undergoing Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer.
1/2020	Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
11/2019	Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment.
11/2019	Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
5/2019	Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.
4/2019	PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer?
1/2019	Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review.
1/2019	Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.
12/2018	PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Mollo Research Topics

Disease

12	Neoplasms (Cancer) 12/2022 - 01/2017
12	Endometrial Neoplasms (Endometrial Cancer) 09/2022 - 12/2018
10	Endometrial Hyperplasia 09/2022 - 12/2018
5	Infertility (Sterility) 01/2019 - 11/2004
3	Endometriosis 11/2022 - 12/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2020
3	Spontaneous Abortion (Miscarriage) 11/2020 - 12/2008
3	Thrombophilia 12/2008 - 11/2004
2	Metaplasia 08/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 08/2022 - 01/2020
2	Carcinogenesis 01/2021 - 09/2019
2	Turcot syndrome 01/2021 - 01/2020
2	Hemorrhage 01/2021 - 12/2015
2	Cicatrix (Scar) 01/2021 - 08/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2020
2	Ovarian Cysts (Ovarian Cyst) 01/2020 - 09/2011
2	Cysts 01/2020 - 09/2011
2	Endometrioid Carcinoma 11/2019 - 11/2019
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2005 - 11/2004
1	Adenomyoma 10/2022
1	Adenomyosis 05/2022
1	Postoperative Pain 04/2022
1	Leiomyosarcoma 03/2022
1	Ovarian Torsion 01/2022
1	Stillbirth 11/2020
1	Birth Weight (Birth Weights) 11/2020
1	COVID-19 11/2020
1	Fetal Death 11/2020
1	Perinatal Death 11/2020
1	Microsatellite Instability 07/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Ascites 01/2020
1	Diabetes Mellitus 11/2019
1	Pre-Eclampsia (Preeclampsia) 03/2019
1	Overweight 01/2019
1	Angular Pregnancy 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 10/2018
1	Residual Neoplasm 10/2018
1	Hypotension (Low Blood Pressure) 02/2018
1	Ovarian Hyperstimulation Syndrome 01/2018
1	Necrosis 01/2017
1	Infections 12/2015
1	Intraoperative Complications 12/2015
1	Leiomyoma (Uterine Fibroids) 09/2015
1	Ectopic Pregnancy 08/2014
1	Polyps 11/2011
1	Follicular Cyst (Follicular Cysts) 09/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 03/2022 - 03/2019
4	CateninsIBA 01/2022 - 01/2019
4	Progestins (Progestagens)IBA 11/2019 - 12/2018
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019 - 09/2011
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2020
2	Estrogen ReceptorsIBA 01/2021 - 01/2019
2	PlatinumIBA 01/2021 - 12/2020
2	Oxygen (Dioxygen)IBA 11/2020 - 01/2019
2	factor V LeidenIBA 12/2008 - 11/2004
1	Troleandomycin (TAO)FDA Link 12/2022
1	lipoarabinomannan (LAM)IBA 11/2022
1	Dual Specificity Phosphatase 6IBA 09/2022
1	alpha-methylacyl-CoA racemaseIBA 08/2022
1	Hemoglobins (Hemoglobin)IBA 04/2022
1	Differentiation AntigensIBA 01/2021
1	Claudin-4IBA 01/2021
1	Exonucleases (3' 5' Exonuclease)IBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2020
1	Calmodulin-Binding Proteins (Caldesmon)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 09/2019
1	Levonorgestrel (Plan B)FDA LinkGeneric 05/2019
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 04/2019
1	TensinsIBA 04/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2019
1	Hypnotics and Sedatives (Sedatives)IBA 01/2019
1	Progesterone FDA LinkGeneric 01/2019
1	lactate dehydrogenase 1 (LDH1)IBA 10/2018
1	IsoenzymesIBA 10/2018
1	Indicators and Reagents (Reagents)IBA 02/2018
1	Human Follicle Stimulating HormoneIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Testosterone (Sustanon)FDA Link 01/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	deslorelinIBA 01/2017
1	Benzene (Benzole)IBA 01/2014
1	Interferon-gamma (Interferon, gamma)IBA 11/2011
1	Buserelin (Suprefact)IBA 09/2011

Therapy/Procedure

8	Conservative Treatment 10/2022 - 09/2015
6	Hysterectomy 10/2022 - 10/2018
5	Therapeutics 01/2021 - 12/2008
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2020
2	Hysteroscopes 01/2021 - 09/2007
2	Cesarean Section (Caesarean Section) 01/2021 - 08/2014
2	Intrauterine Devices (Intrauterine Device) 11/2020 - 05/2019
2	Electrodes (Electrode) 01/2019 - 09/2007
2	Uterine Myomectomy 10/2018 - 09/2015
2	Aftercare (After-Treatment) 01/2017 - 09/2011
2	Operative Time 12/2015 - 01/2011
1	Cystectomy 01/2022
1	Morcellation 10/2018